ELAN News and Press, Elanco Animal Health Incorporated From 07/07/24

ELAN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Elanco Animal Health Incorporated (NYSE: ELAN) Investors with Significant Losses to Contact the Firm ELAN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Elanco Animal Health Incorpo...

SAN FRANCISCO, CA / ACCESSWIRE / July 6, 2024 / Hagens Berman urges Elanco Animal Health Incorporated (NYSE: ELAN) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com 844-916-0895 ...

SAN FRANCISCO, July 05, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Elanco Animal Health Incorporated (NYSE: ELAN) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com...

NEW YORK CITY, NY / ACCESSWIRE / July 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities are encouraged to obtain additi...

2024-07-01 10:48:16 ET More on S&P 500 Index: Inflation Fears To Shift To Growth Concerns Weekly Market Pulse: The S&P 500 Rules Everything Around Me Nearing Full Froth: A Look Inside The Current Market Bubble Nasdaq, S&P, Dow trade higher as mark...

NEW YORK CITY, NY / ACCESSWIRE / July 1, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities are encouraged to obtain additi...

2024-07-01 07:00:08 ET David Westenberg from Piper Sandler issued a price target of $16.00 for ELAN on 2024-07-01 06:25:00. The adjusted price target was set to $16.00. At the time of the announcement, ELAN was trading at $14.43. The overall price target consensus is at ...

2024-06-30 05:58:23 ET Summary Elanco Animal Health shares have dropped over 20% due to a delay in the innovative product pipeline, but potential for a recovery remains. The company's divestment of the aqua business at a high sales multiple reduced leverage ratios, improving the o...

MONSEY, N.Y., June 28, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Elanco Animal Health Incorporated (NYSE:ELAN) (“Elanco”) has violated federal securities laws after the company announced that the U.S. label for its new eczema treatment...

2024-06-27 10:50:00 ET More on Elanco Elanco Animal Health: At Least Fully Valued After Rally Elanco Animal Health (ELAN) Q1 2024 Earnings Call Transcript Elanco Animal Health Incorporated 2024 Q1 - Results - Earnings Call Presentation Elanco wins FDA nod for...